Richard Kim, Avadel, on the Future of Narcolepsy Care
Richard Kim, Chief Commercial Officer of Avadel, spoke about the “exciting” future of narcolepsy care, helped in part by the innovations developed by Avadel.
Comparative Efficacy of Therapies for Locally Advanced Cervical Cancer
Organoids Offer Insight Into Melanoma Drug Resistance
Clinical Predictors of Early Cutaneous Melanoma Recurrence